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Summary
The transcription factors OCT4, SOX2, and NANOG
have essential roles in early development and are re-
quired for the propagation of undifferentiated embry-
onic stem (ES) cells in culture. To gain insights into
transcriptional regulation of human ES cells, we have
identified OCT4, SOX2, and NANOG target genes
using genome-scale location analysis. We found, sur-
prisingly, that OCT4, SOX2, and NANOG co-occupy a
substantial portion of their target genes. These target
genes frequently encode transcription factors, many
of which are developmentally important homeodo-
main proteins. Our data also indicate that OCT4,
SOX2, and NANOG collaborate to form regulatory cir-
cuitry consisting of autoregulatory and feedforward
loops. These results provide new insights into the
transcriptional regulation of stem cells and reveal
how OCT4, SOX2, and NANOG contribute to pluripo-
tency and self-renewal.
Introduction
Mammalian development requires the specification of
over 200 unique cell types from a single totipotent cell.
Embryonic stem (ES) cells are derived from the inner
cell mass (ICM) of the developing blastocyst and can
be propagated in culture in an undifferentiated state
while maintaining the capacity to generate any cell type
in the body. The recent derivation of human ES cells*Correspondence: young@wi.mit.edu
6 These authors contributed equally to this work.provides a unique opportunity to study early develop-
ment and is thought to hold great promise for regenera-
tive medicine (Pera and Trounson, 2004; Reubinoff et
al., 2000; Thomson et al., 1998). An understanding of
the transcriptional regulatory circuitry that is responsi-
ble for pluripotency and self-renewal in human ES cells
is fundamental to understanding human development
and realizing the therapeutic potential of these cells.
Homeodomain transcription factors are evolutionarily
conserved and play key roles in cell-fate specification
in many organisms (Hombria and Lovegrove, 2003).
Two such factors, OCT4/POU5F1 and NANOG, are essen-
tial regulators of early development and ES cell identity
(Chambers et al., 2003; Hay et al., 2004; Matin et al.,
2004; Mitsui et al., 2003; Nichols et al., 1998; Zaehres
et al., 2005). Several genetic studies in mouse suggest
that these regulators have distinct roles but may func-
tion in related pathways to maintain the developmental
potential of these cells (Chambers, 2004). For example,
disruption of OCT4 or NANOG results in the inappropri-
ate differentiation of ICM and ES cells to trophectoderm
and extra-embryonic endoderm, respectively (Cham-
bers et al., 2003; Mitsui et al., 2003; Nichols et al., 1998).
However, overexpression of OCT4 in ES cells leads to
a phenotype that is similar to loss of NANOG function
(Chambers et al., 2003; Mitsui et al., 2003; Nichols et
al., 1998; Niwa et al., 2000). Knowledge of the set of
genes regulated by these two transcription factors
might reveal why manipulation of OCT4 and NANOG
results in these phenotypic consequences.
OCT4 is known to interact with other transcription
factors to activate and repress gene expression in
mouse ES cells (Pesce and Schöler, 2001). For exam-
ple, OCT4, a member of the POU (PIT/OCT/UNC) class
of homeodomain proteins, can heterodimerize with the
HMG-box transcription factor, SOX2, to affect the ex-
pression of several genes in mouse ES cells (Botquin
et al., 1998; Nishimoto et al., 1999; Yuan et al., 1995).
The cooperative interaction of POU homeodomain and
HMG factors is thought to be a fundamental mecha-
nism for the developmental control of gene expression
(Dailey and Basilico, 2001). The extent to which ES cell
gene regulation is accomplished by OCT4 through an
OCT4/SOX2 complex and whether NANOG has a role
in this process are unknown.
OCT4, SOX2, and NANOG are thought to be central
to the transcriptional regulatory hierarchy that specifies
ES cell identity because of their unique expression pat-
terns and their essential roles during early development
(Avilion et al., 2003; Chambers et al., 2003; Hart et al.,
2004; Lee et al., 2004; Mitsui et al., 2003; Nichols et al.,
1998; Schöler et al., 1990). Studies in a broad range of
eukaryotes have shown that transcriptional regulators
that have key roles in cellular processes frequently reg-
ulate other regulators associated with that process
(Guenther et al., 2005; Lee et al., 2002; Odom et al.,
2004). It is likely that the key stem cell regulators bind
and regulate genes encoding other transcriptional reg-
ulators, which in turn determine the developmental po-
tential of these cells, but we currently lack substantial
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948Figure 1. Genome-Wide Location Analysis in Human Embryonic Stem Cells
(A) DNA segments bound by transcriptional regulators were identified using chromatin immunoprecipitation (ChIP) and identified with DNA
microarrays containing 60-mer oligonucleotide probes covering the region from −8 kb to +2 kb for 17,917 annotated transcription start sites
for human genes. ES cell growth and quality control, ChIP protocol, DNA microarray probe design, and data analysis methods are described
in detail in Experimental Procedures and Supplemental Data.
(B) Examples of OCT4 bound regions. Plots display unprocessed ChIP-enrichment ratios for all probes within a genomic region. Genes are
shown to scale below plots (exons and introns are represented by thick vertical and horizontal lines, respectively), and the genomic region
represented is indicated beneath the plot. The transcription start site and transcript direction are denoted by arrows.knowledge of the regulatory circuitry of ES cells and
other vertebrate cells.
To further our understanding of the means by which
OCT4, SOX2, and NANOG control the pluripotency and
self-renewal of human ES cells, we have used genome-
scale location analysis (chromatin immunoprecipitation
coupled with DNA microarrays) to identify the target
genes of all three regulators in vivo. The results reveal
that OCT4, SOX2, and NANOG co-occupy the promot-
ers of a large population of genes, that many of these
target genes encode developmentally important ho-
meodomain transcription factors, and that these regu-
lators contribute to specialized regulatory circuits in
ES cells.
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CT4 Promoter Occupancy in Human ES Cells
NA sequences occupied by OCT4 in human H9 ES
ells (NIH code WA09; Supplemental Data) were iden-
ified in a replicate set of experiments using chromatin
mmunoprecipitation (ChIP) combined with DNA micro-
rrays (Figure 1A and Supplemental Data). For this pur-
ose, DNA microarrays were designed that contain 60-
er oligonucleotide probes covering the region from −8
b to +2 kb relative to the transcript start sites for
7,917 annotated human genes. Although some tran-
cription factors are known to regulate genes from dis-
ances greater than 8 kb, 98% of known binding sites
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949for human transcription factors occur within 8 kb of tar-
get genes (Figure S1). The sites occupied by OCT4
were identified as peaks of ChIP-enriched DNA that
span closely neighboring probes (Figure 1B). OCT4 was
associated with 623 (3%) of the promoter regions for
known protein-coding genes and 5 (3%) of the promot-
ers for known miRNA genes in human ES cells (Table S2).
Two lines of evidence suggested that this protein-
DNA interaction dataset is of high quality. First, the
genes occupied by OCT4 in our analysis included many
previously identified or supposed target genes in mouse
ES cells or genes whose transcripts are highly enriched
in ES cells, including OCT4, SOX2, NANOG, LEFTY2/
EBAF, CDX2, HAND1, DPPA4, GJA1/CONNEXIN43,
FOXO1A, CRIPTO/TDGF1, and ZIC3 (Abeyta et al.,
2004; Brandenberger et al., 2004; Catena et al., 2004;
Kuroda et al., 2005; Niwa, 2001; Okumura-Nakanishi et
al., 2005; Rodda et al., 2005; Sato et al., 2003; Wei et
al., 2005) (Table S2). Second, we have used improved
protocols and DNA microarray technology in these ex-
periments (Supplemental Data) that should reduce false
positive rates relative to those obtained in previous ge-
nome-scale experiments (Odom et al., 2004). By using
this new technology with yeast transcription factors,
where considerable prior knowledge of transcription
factor binding sites has been established, we estimated
that this platform has a false positive rate of <1% and
a false negative rate of 20% (Supplemental Data).
OCT4, SOX2, and NANOG Co-Occupy
Many Target Genes
We next identified, with location analysis, protein-cod-
ing and miRNA genes targeted by the stem cell regula-
tors SOX2 and NANOG. SOX2 and NANOG were found
associated with 1271 (7%) and 1687 (9%), respectively,
of the promoter regions for known protein-coding
genes in human ES cells (Tables S2–S4). It was immedi-
ately evident that many of the target genes were shared
by OCT4, SOX2, and NANOG (Figure 2A). Examples of
protein-coding genes that are co-occupied by the three
regulators are shown in Figure 2B (Table S5). Control
experiments showed that the set of promoters bound
by the cell-cycle transcription factor E2F4 in these hu-
man ES cells did not overlap substantially with those
bound by the three stem cell regulators (Tables S2 and
S6). We found that OCT4, SOX2, and NANOG together
occupy at least 353 genes in human ES cells.
Previous studies in murine ES cells have shown that
SOX2 and OCT4 can interact to synergistically activate
transcription of target genes and that this activity is de-
pendent upon the juxtaposition of OCT4 and SOX2
binding sites (Ambrosetti et al., 1997; Remenyi et al.,
2004). Our results revealed that approximately half of
the promoter regions occupied by OCT4 were also
bound by SOX2 in human ES cells (Figure 2A; Table
S2). It was surprising, however, to find that >90% of
promoter regions bound by both OCT4 and SOX2 were
also occupied by NANOG. Furthermore, we found that
OCT4, SOX2, and NANOG binding sites occurred in
close proximity at nearly all of the genes that they co-
occupied (Figure 2C). These data suggest that OCT4,
SOX2, and NANOG function together to regulate a sig-
nificant proportion of their target genes in human ES
cells.A class of small noncoding RNAs known as micro-
RNAs (miRNA) play vital roles in gene regulation, and
recent studies indicate that more than a third of mam-
malian protein-coding genes are conserved miRNA tar-
gets (Bartel, 2004; Lewis et al., 2005). ES cells lacking
the machinery that processes miRNA transcripts are un-
able to differentiate (Kanellopoulou et al., 2005). More-
over, recent evidence indicates that microRNAs play an
important role in organismal development through reg-
ulation of gene expression (Pasquinelli et al., 2005).
OCT4, SOX2, and NANOG were found associated with
14 miRNA genes and co-occupied the promoters of at
least two miRNA genes, mir-137 and mir-301 (Table 1).
Our results suggest that miRNA genes are likely regu-
lated by OCT4, SOX2, and NANOG in human ES cells
and are important components of the transcriptional
regulatory circuitry in these cells.
ES Cell Transcription Factors Occupy
Active and Inactive Genes
OCT4 and SOX2 are known to be involved in both gene
activation and repression in vivo (Botquin et al., 1998;
Nishimoto et al., 1999; Yuan et al., 1995), so we sought
to identify the transcriptional state of genes occupied
by the stem cell regulators. To this end, the set of genes
bound by OCT4, SOX2, and NANOG were compared to
gene expression datasets generated from multiple ES
cell lines (Abeyta et al., 2004; Brandenberger et al.,
2004; Sato et al., 2003; Wei et al., 2005) to identify tran-
scriptionally active and inactive genes (Table S2). The
results showed that one or more of the stem cell tran-
scription factors occupied 1303 actively transcribed
genes and 957 inactive genes.
The importance of OCT4, SOX2, and NANOG for early
development and ES cell identity led us to focus addi-
tional analyses on the set of 353 genes that are co-
occupied by these regulators in human ES cells (Table
S5). We first identified transcriptionally active genes.
Transcripts were consistently detected in ES cells for
approximately half of the genes co-bound by OCT4,
SOX2, and NANOG. Among these active genes, several
encoding transcription factors (e.g., OCT4, SOX2,
NANOG, STAT3, ZIC3) and components of the Tgf-β
(e.g., TDGF1, LEFTY2/EBAF) and Wnt (e.g., DKK1,
FRAT2) signaling pathways were notable targets. Re-
cent studies have shown that Tgf-β and Wnt signaling
play a role in pluripotency and self-renewal in both
mouse and human ES cells (James et al., 2005; Sato et
al., 2004). These observations suggest that OCT4,
SOX2, and NANOG promote pluripotency and self-
renewal through positive regulation of their own genes
and genes encoding components of these key signal-
ing pathways.
Among transcriptionally inactive genes co-occupied
by OCT4, SOX2, and NANOG, we noted a striking en-
richment for transcription factor genes (p < 10−18; Table
S7), many of which have been implicated in develop-
mental processes. These included genes that specify
transcription factors important for differentiation into
extra-embryonic, endodermal, mesodermal, and ecto-
dermal lineages (e.g., ESX1l, HOXB1, MEIS1, PAX6,
LHX5, LBX1, MYF5, ONECUT1) (Table S5). Moreover,
nearly half of the transcription factor genes that were
Cell
950Figure 2. OCT4, SOX2, and NANOG Target
Genes in Human ES Cells
(A) Venn diagram representing the overlap of
OCT4, SOX2, and NANOG promoter bound
regions.
(B) Representative examples of protein-cod-
ing genes co-occupied by OCT4, SOX2, and
NANOG. Plots display unprocessed ChIP-
enrichment ratios for all probes within a ge-
nomic region. Genes are shown to scale rel-
ative to their chromosomal position. Exons
and introns are represented by thick verti-
cal and horizontal lines, respectively. The
start and direction of transcription are de-
noted by arrows. Green, red, and purple lines
represent NANOG, SOX2, and OCT4 bound
regions, respectively.
(C) OCT4, SOX2, and NANOG bind in close
proximity. The distances between the mid-
point of bound regions for pairs of transcrip-
tion factors was calculated for the 353 re-
gions bound by all three transcription
factors. Negative and positive values indi-
cate whether the first factor is upstream or
downstream of the second factor in relation
to the gene. The frequency of different dis-
tances between the bound regions is plotted
as a histogram.Sato et al., 2003) from ES cells and a compendium of
Table 1. miRNA Loci near OCT4, SOX2, and NANOG Bound
Regions
Transcription Factor
miRNA OCT4 SOX2 NANOG
mir-7-1 +
mir-10a +
mir-22 + +
mir-32 + +
mir-128a +
mir-135b + +
mir-137 + + +
mir-196a-1 +
mir-196b +
mir-204 + +
mir-205 + +
mir-301 + + +
mir-361 +
mir-448 +
Proximal binding of OCT4, SOX2, and NANOG to miRNAs from the
RFAM database. Transcription factors bound are indicated by a
“+.”
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abound by the three regulators and transcriptionally in-
active encoded developmentally important homeodo-
main proteins (Table 2). These results demonstrate that
OCT4, SOX2, and NANOG occupy a set of repressed
genes that are key to developmental processes.
To determine which of the OCT4, SOX2, and NANOG
bound genes were preferentially expressed in ES cells,
we compared expression datasets (Abeyta et al., 2004;
d
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eifferentiated tissues and cell types (Su et al., 2004)
Figure 3; Supplemental Data). It was notable that
PPA4, TDGF1, OCT4, NANOG, and LEFTY2 were at
he top of the rank order list of genes that are bound
nd preferentially expressed in ES cells (Figure 3A). All
ive of these genes have been implicated in pluripo-
ency (James et al., 2005; Mitsui et al., 2003; Chambers
t al., 2003; Nichols et al., 1998; Bortvin et al., 2003).
oreover, several genes that encode developmentally
mportant homeodomain proteins such as DLX5, HOXB1,
HX5, TITF1, LBX1, and HOP were at the bottom of this
ist, indicating that they are preferentially repressed in
S cells.
The observation that OCT4, SOX2, and NANOG
ound to transcriptionally active genes that have roles
n pluripotency and transcriptionally inactive genes that
romote development suggests that these binding
vents are regulatory. Two additional lines of evidence
ndicated that many of the binding events identified in
his study contribute to regulation of their target genes.
irst, some of the genes identified here (e.g., OCT4,
OX2, and NANOG) were previously shown to be regu-
ated by OCT4 and SOX2 in mouse ES cells (Catena et
l., 2004; Kuroda et al., 2005, Okumura-Nakanishi et al.,
005; Rodda et al., 2005). Second, we further explored
he hypothesis that bound genes are regulated by these
ranscription factors by taking advantage of the fact
hat OCT4 and NANOG are expressed in ES cells, but
heir expression is rapidly downregulated upon differ-
ntiation. We compared the expression of OCT4, SOX2,
nd NANOG occupied genes in human ES cells with
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951Table 2. Examples of Inactive Homeodomain Genes Co-occupied by OCT4, SOX2, and NANOG
Gene Symbol Entrez Gene ID Gene Name
ATBF1 463 AT binding transcription factor 1
DLX1 1745 distal-less homeobox 1
DLX4 1748 distal-less homeobox 4
DLX5 1749 distal-less homeobox 5
EN1 2019 engrailed homolog 1
ESX1L 80712 extraembryonic, spermatogenesis, homeobox 1-like
GBX2 2637 gastrulation brain homeobox 2
GSC 145258 goosecoid
HOP 84525 homeodomain-only protein
HOXB1 3211 homeobox B1
HOXB3 3213 homeobox B3
HOXC4 3221 homeobox C4
IPF2 3651 insulin promoter factor 2
ISL1 3670 ISL1 transcription factor, LIM/homeodomain (islet-1)
LBX1 10660 transcription factor similar to D. melanogaster homeodomain protein lady bird late
LHX2 9355 LIM homeobox 2
LHX5 64211 LIM homeobox 5
MEIS1 4211 myeloid ecotropic viral integration site 1 homolog (mouse)
NKX2-2 4821 NK2 transcription factor related, locus 2 (Drosophila)
NKX2-3 159296 NK2 transcription factor related, locus 3 (Drosophila)
ONECUT1 3175 one cut domain, family member 1
OTP 23440 orthopedia homolog (Drosophila)
OTX1 5013 orthodenticle homolog 1 (Drosophila)
PAX6 5080 paired box gene 6
TITF1 7080 thyroid transcription factor 1expression patterns in 79 differentiated cell types (Su
et al., 2004) (Supplemental Data) and focused the
analysis on transcription factor genes because these
were the dominant functional class targeted by the ES
cell regulators (Figure 3B). We expected that for any
set of genes, there would be a characteristic change in
expression levels between ES cells and differentiated
cells. If OCT4, SOX2, and NANOG do not regulate the
genes they occupy, then these genes should have the
same general expression profile as the control popula-
tion. We found, however, a significant shift in the distri-
bution of expression changes for genes occupied by
OCT4, SOX2, and NANOG (p value < 0.001). Taken to-
gether, these data support the model that OCT4, SOX2,
and NANOG functionally regulate the genes they oc-
cupy and suggest that loss of these regulators upon
differentiation results in increased expression of genes
necessary for development and reduced expression of
a set of genes required for the maintenance of stem
cell identity.
Our results suggest that OCT4, SOX2, and NANOG
contribute to pluripotency and self-renewal by activa-
ting their own genes and genes encoding components
of key signaling pathways and by repressing genes that
are key to developmental processes. It is presently un-
clear how the three key regulators can activate some
genes and repress others. It is likely that the activity of
these key transcription factors is further controlled by
additional cofactors, by the precise levels of OCT4,
SOX2, and NANOG, and by posttranslational modifica-
tions.
Core Transcriptional Regulatory Circuitry in ES Cells
In order to identify regulatory network motifs associ-
ated with OCT4, SOX2, and NANOG, we assumed that
regulator binding to a gene implies regulatory controland used algorithms that were previously devised to
discover such regulatory circuits in yeast (Lee et al.,
2002). The simplest units of commonly used transcrip-
tional regulatory network architecture, or network mo-
tifs, provide specific regulatory capacities such as posi-
tive and negative feedback loops to control the levels
of their components (Lee et al., 2002; Milo et al., 2002;
Shen-Orr et al., 2002).
Our data indicated that OCT4, SOX2, and NANOG
form feedforward loops that involve at least 353 protein
coding and 2 miRNA genes (Figure 4A). Feedforward-
loop motifs contain a regulator that controls a second
regulator and have the additional feature that both reg-
ulators bind a set of common target genes. The feed-
forward loop has multiple regulatory capacities that
may be especially useful for stem cells. When both reg-
ulators are positive, the feedforward loop can provide
consistent activity that is relatively insensitive to tran-
sient changes in input (Mangan et al., 2003; Shen-Orr
et al., 2002). If the regulators have positive and negative
functions, the feedforward loop can act as a switch that
enables a rapid response to inputs by providing a time-
sensitive delay where the downstream regulator acts to
counter the effects of the upstream regulator in a de-
layed fashion (Mangan and Alon, 2003; Mangan et al.,
2003). In ES cells, both regulatory capacities could be
useful for maintaining the pluripotent state while retain-
ing the ability to react appropriately to differentiation
signals. Previous studies have shown that feedforward-
loop architecture has been highly favored during the
evolution of transcriptional regulatory networks in less
complex eukaryotes (Lee et al., 2002; Ma et al., 2004;
Milo et al., 2002; Resendis-Antonio et al., 2005; Shen-Orr
et al., 2002). Our data suggest that feedforward regulation
is an important feature of human ES cells as well.
Our results also showed that OCT4, SOX2, and NANOG
Cell
952Figure 3. Expression of OCT4, SOX2, and
NANOG Co-Occupied Genes
(A) Affymetrix expression data for ES cells
were compared to a compendium of expres-
sion data from 158 experiments representing
79 other differentiated tissues and cell types
(Supplemental data). Ratios were generated
by comparing gene expression in ES cells to
the median level of gene expression across
all datasets for each individual gene. Genes
were ordered by relative expression in ES
cells, and the results were clustered by
expression experiment using hierarchical
clustering. Each gene is represented as a
separate row and individual expression ex-
periments are in separate columns. Red indi-
cates higher expression in ES cells relative
to differentiated cells. Green indicates lower
expression in ES cells relative to differenti-
ated cells. Examples of bound genes that are
at the top and bottom of the rank order list
are shown.
(B) Relative levels of gene expression in H9
ES cells compared to differentiated cells
were generated and converted to log2 ratios.
The distribution of these fold changes was
calculated to derive a profile for different
sets of genes. Data are shown for the distri-
bution of expression changes between H9
ES cells and differentiated tissues for tran-
scription factor genes that are not occupied
by OCT4, SOX2, and NANOG (solid black
line) and transcription factor genes occupied
by all three (dotted line). The change in rela-
tive expression is indicated on the x axis,
and the numbers of genes in each bin are
indicated on the y axes (left axis for unoccu-
pied genes, right axis for occupied genes).
The shift in distribution of expression changes
for genes occupied by OCT4, SOX2, and
NANOG is significant (p value < 0.001 using
a two-sampled Kolmogorov-Smirnov test),
consistent with the model that OCT4, SOX2,
and NANOG are contributing to the regula-
tion of these genes.cells (Chambers et al., 2003; Mitsui et al., 2003; Nicholstwo regulators. Our results argue that the levels and
Figure 4. Transcriptional Regulatory Motifs in Human ES Cells
(A) An example of feedforward transcriptional regulatory circuitry in
human ES cells. Regulators are represented by blue circles; gene
promoters are represented by red rectangles. Binding of a regulator
to a promoter is indicated by a solid arrow. Genes encoding regula-
tors are linked to their respective regulators by dashed arrows.together bound to the promoters of their own genes,
forming interconnected autoregulatory loops (Figure
4B; see also Figure S2). Transcriptional regulation of
OCT4, SOX2, and NANOG by the OCT4-SOX2 complex
was recently described in murine ES cells (Catena et
al., 2004; Kuroda et al., 2005; Okumura-Nakanishi et al.,
2005; Rodda et al., 2005). Our data indicate that this
autoregulatory loop is conserved in human ES cells
and, more importantly, that NANOG is a component of
the regulatory apparatus at these genes. Thus, it is
likely that the expression and function of these three
key stem cell factors are inextricably linked to one an-
other. Autoregulation is thought to provide several
advantages, including reduced response time to envi-
ronmental stimuli and increased stability of gene ex-
pression (McAdams and Arkin, 1997; Rosenfeld et al.,
2002; Shen-Orr et al., 2002; Thieffry et al., 1998).
The autoregulatory and feedforward circuitry de-
scribed here may provide regulatory mechanisms by
which stem cell identity can be robustly maintained yet
permit cells to respond appropriately to developmental
cues. Modifying OCT4 and NANOG levels and function
can change the developmental potential of murine ES
e
p
dt al., 1998; Niwa et al., 2000), and this might be inter-
reted as being a consequence of perturbing indepen-
ent regulatory pathways under the control of these(B) The interconnected autoregulatory loop formed by OCT4, SOX2,
and NANOG.
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953functions of these key stem cell regulators are tightly
linked at both target genes and at their own promoters
and thus provide an additional framework for interpre-
ting the genetic studies. Changes in the relative stoichi-
ometry of these factors would disturb the autoregula-
tory and feedforward circuitry, producing changes in
global gene regulation and thus cell fate.
Expanded Transcriptional Regulatory Circuitry
An initial model for ES cell transcriptional regulatory cir-
cuitry was constructed by identifying OCT4, SOX2, and
NANOG target genes that encode transcription factors
and chromatin regulators and integrating knowledge of
the functions of these downstream regulators in both
human and mouse based on the available expression
studies and literature (Figure 5). The model includes a
subset of active and a subset of repressed target genes
based on the extensive expression characterization of
the 353 co-bound genes as described earlier. The
active targets include genes encoding components of
chromatin remodeling and histone-modifying com-Figure 5. Core Transcriptional Regulatory Network in Human ES
Cells
A model for the core transcriptional regulatory network was con-
structed by identifying OCT4, SOX2, and NANOG target genes that
encode transcription factors and chromatin regulators and integ-
rating knowledge of the functions of these downstream regulators
based on comparison to multiple expression datasets (Supplemen-
tal Data) and to the literature. A subset of active and inactive genes
co-occupied by the three factors in human ES cells is shown here.
Regulators are represented by blue circles; gene promoters are
represented by red rectangles; gray boxes represent putative
downstream target genes. Positive regulation was assumed if the
target gene was expressed whereas negative regulation was as-
sumed if the target gene was not transcribed.plexes (e.g., SMARCAD1, MYST3, and SET), which mayhave general roles in transcriptional regulation, and
genes encoding transcription factors (e.g., REST, SKIL,
HESX1, and STAT3), which themselves are known to
regulate specific genes. For instance, REST has re-
cently been shown to be highly abundant in ES cells
and functions in part to repress neuronal specific genes
(Ballas et al., 2005). Previous studies have proposed
that NANOG may function through the Tgf-β pathway
in ES cells (Chambers, 2004). Our model suggests that
this occurs through direct regulation of key compo-
nents of this pathway (e.g., TDFG1, LEFTY2/EBAF) and
through regulation of at least one transcription factor,
SKIL, which controls the activity of downstream com-
ponents of this pathway (SMAD2, SMAD4) (He et al.,
2003). Our data also reveal that OCT4, SOX2, and
NANOG co-occupy STAT3, a key regulator of self-
renewal in mouse ES cells (Chambers, 2004), suggest-
ing that STAT3 may also play a role in human ES cells.
The model described in Figure 5 also depicts a sub-
set of the genes bound by OCT4, SOX2, and NANOG
that are inactive and that encode transcription factors
that have key roles in differentiation and development.
These include regulators with demonstrated roles in
development of all embryonic lineages. This initial
model for ES cell transcriptional regulatory circuitry is
consistent with previous genetic studies in mice that
suggest that OCT4 and NANOG maintain pluripotency
through repression of differentiation programs (Cham-
bers et al., 2003; Mitsui et al., 2003; Niwa et al., 2000).
This model also provides a mechanistic framework for
understanding how this is accomplished through regu-
lation of specific sets of genes that control cell-fate
specification.
Concluding Remarks
Discovering how gene expression programs are con-
trolled in living cells promises to improve our under-
standing of cell biology, development, and human
health. Identifying the target genes for key transcrip-
tional regulators of human stem cells is a first critical
step in the process of understanding these transcrip-
tional regulatory networks and learning how they con-
trol cell identity. Mapping OCT4, SOX2, and NANOG to
their binding sites within known promoters has re-
vealed that these regulators collaborate to form in ES
cells regulatory circuitry consisting of specialized auto-
regulatory and feedforward loops. Continued advances
in our ability to culture and genetically manipulate hu-
man ES cells will allow us to test and manipulate this
circuitry. Identification of the targets of additional tran-
scription factors and chromatin regulators using the ap-
proaches described here should allow investigators to
produce a more comprehensive map of transcriptional
regulatory circuitry in these cells. Connecting signaling
pathways to this circuit map may reveal how these plu-
ripotent cells can be stimulated to differentiate into dif-
ferent cell types or how to reprogram differentiated
cells back to a pluripotent state.
Experimental Procedures
Growth Conditions for Human Embryonic Stem Cells
Human embryonic stem (ES) cells were obtained from WiCell (Mad-
ison, Wisconsin; NIH Code WA09). Detailed protocol information on
Cell
954human ES cell growth conditions and culture reagents are available
at http://www.mcb.harvard.edu/melton/hues. Briefly, passage 34 cells
were grown in KO-DMEM medium supplemented with serum re-
placement, basic fibroblast growth factor (bFGF), recombinant hu-
man leukemia inhibitory factor (LIF), and a human plasma protein
fraction. In order to minimize any MEF contribution in our analysis,
H9 cells were cultured on a low density of irradiated murine embry-
onic fibroblasts (ICR MEFs) resulting in a ratio of approximately
>8:1 H9 cell to MEF. The culture of H9 on low-density MEFs had no
adverse effects on cell morphology, growth rate, or undifferentiated
status as compared to cells grown under typical conditions. In ad-
dition, immunohistochemistry for pluripotency markers (e.g., OCT4,
SSEA-3) indicated that H9 cells grown on a minimal feeder layer
maintained the ability to generate derivates of ectoderm, meso-
derm, and endoderm upon differentiation (Figures S3 and S4).
Antibodies
The NANOG (AF1997) and SOX2 (AF2018) antibodies used in this
study were immunoaffinity purified against the human proteins and
shown to recognize their target proteins in Western blots and by
immunocytochemistry (R&D Systems Minneapolis, Minnesota).
Multiple OCT4 antibodies directed against different portions of the
protein (AF1759 R&D Systems, sc-8628 Santa Cruz, sc-9081 Santa
Cruz), some of which were immunoaffinity purified, were used in
this study and have been shown to recognize their target protein
in Western blots and by immunocytochemistry. The E2F4 antibody
used in this study was obtained from Santa Cruz (sc-1082) and
has been shown to recognize E2F4-responsive genes identified in
previous ChIP studies (Table S2) (Ren et al., 2002; Weinmann et
al., 2002).
Chromatin Immunoprecipitation
Protocols describing all materials and methods can be downloaded
from http://jura.wi.mit.edu/young/hESRegulation/.
Human embryonic stem cells were grown to a final count of 5 ×
107–1 × 108 cells for each location analysis reaction. Cells were
chemically crosslinked by the addition of one-tenth volume of fresh
11% formaldehyde solution for 15 min at room temperature. Cells
were rinsed twice with 1 × PBS and harvested using a silicon
scraper and flash frozen in liquid nitrogen and stored at −80°C prior
to use. Cells were resuspended, lysed in lysis buffers, and soni-
cated to solubilize and shear crosslinked DNA. Sonication condi-
tions vary depending on cells, culture conditions, crosslinking, and
equipment. We used a Misonix Sonicator 3000 and sonicated at
power 7 for 10 × 30 s pulses (90 s pause between pulses) at 4°C
while samples were immersed in an ice bath. The resulting whole-
cell extract was incubated overnight at 4°C with 100 l of Dynal
Protein G magnetic beads that had been preincubated with 10 g
of the appropriate antibody. Beads were washed five times with
RIPA buffer and one time with TE containing 50 mM NaCl. Bound
complexes were eluted from the beads by heating at 65°C with
occasional vortexing, and crosslinking was reversed by overnight
incubation at 65°C. Whole-cell extract DNA (reserved from the soni-
cation step) was also treated for crosslink reversal. Immunoprecipi-
tated DNA and whole-cell extract DNA were then purified by treat-
ment with RNaseA, proteinase K, and multiple phenol:chloroform:
isoamyl alcohol extractions. Purified DNA was blunted and ligated
to linker and amplified using a two-stage PCR protocol. Amplified
DNA was labeled and purified using Invitrogen Bioprime random
primer labeling kits (immunoenriched DNA was labeled with Cy5
fluorophore, whole-cell extract DNA was labeled with Cy3 fluoro-
phore). Labeled DNA was combined (5–6 g each of immunoen-
riched and whole-cell extract DNA) and hybridized to arrays in Ag-
ilent hybridization chambers for 40 hr at 40°C. Arrays were then
washed and scanned (Supplemental Data).
Array Design and Data Extraction
The design of the 10-slide oligo-based promoter arrays used in
this study and data extraction methods are described in detail in
Supplemental Data. Arrays were manufactured by Agilent Technol-
ogies (http://www.agilent.com).
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Cupplemental Data
upplemental Data include seven figures, seven tables, and Sup-
lemental text and can be found with this article online at http://
ww.cell.com/cgi/content/full/122/6/947/DC1/.
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